Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% ...

A total of 569 articles were submitted in the second national congress on Persian medicine, indicating a forty-percent growth ...

New information to be presented on the study design and methodology of Purespring’s Phase I/IItrial of PS-002, an AAV-based therapy delivering ...

Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the ...

CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...

Family Heart Foundation presents research findings and data focused on genetic dyslipidemias at the AHA Scientific Sessions ...

MRT-8102 is a selective, potent, and durable NEK7 degrader. Activation of the NLRP3 inflammasome critically depends on NEK7. Administration of MRT-8102 led to inhibition of NLRP3 inflammasome in vitro ...

SYRACUSE, NY / ACCESS Newswire / November 11, 2025 / Repair Biotechnologies, Inc. ( today announced the recent presentation of preclinical data at American Heart Association's (AHA) Scientific ...

OSE-Cytomask® platform is an innovative proprietary non-cleavable linker technology to create a new class of regulated and targeted cytokine therapeutics that enables precise cytokine activation on ...

Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

Union Minister of Science & Technology Dr. Jitendra Singh today lauded the launch of the historic ₹1 Lakh Crore Research, Development, and Innovation (RDI) Fund Scheme by PM Narendra Modi, ...